EE447 Cost Implications of Adverse Event Profiles in Second Generation Androgen Receptor Inhibitor (SGARI) Treatments for Non-Metastatic Castration Resistant Prostate Cancer (NMCRPC)

Autor: J Chou, E Bell, I Brewer, S Appukkuttan, J Partridge, SX Kong, R Maclean

Publikováno v: Value in Health. 25:S422

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::31b2886ad8d83624c5c30804dbb6cd29
https://doi.org/10.1016/j.jval.2022.04.695

EE242 Economic Burden Among Chronic Kidney Disease (CKD) Patients with and without Type 2 Diabetes (T2D) in a Commercially Insured/Medicare Advantage (MA) Population in the United States (US)

Autor: H Chung, N Thomas, V Willey, SX Kong, R Singh, R Farej, T Williamson

Publikováno v: Value in Health. 25:S381

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::20c21afb7beb7b6af99dc1f2c32ed0dd
https://doi.org/10.1016/j.jval.2022.04.490

Clinical characteristics and treatment patterns of patients with NTRK fusion-positive solid tumors: A multisite cohort study at US academic cancer centers.

Autor: Willis C; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City., Au T; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City., Hejazi A; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City., Griswold C; Mayo Clinic, Phoenix, AZ., Schabath MB; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Thompson J; Medical College of Wisconsin, Milwaukee., Malhotra J; Rutgers Cancer Institute of New Jersey, New Brunswick., Federman N; University of California, Los Angeles, Jonsson Comprehensive Cancer Center., Ko G; Bayer Pharmaceuticals, Whippany, NJ., Appukkuttan S; Bayer Pharmaceuticals, Whippany, NJ., Warnock N; Bayer Pharmaceuticals, Whippany, NJ., Kong SX; Bayer Pharmaceuticals, Whippany, NJ., Hocum B; Bayer Pharmaceuticals, Whippany, NJ., Brixner D; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City., Stenehjem D; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City.; Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Jul; Vol. 30 (7), pp. 672-683.

Exploring kidney dialysis costs in the United States: a scoping review.

Autor: Stewart F; Cencora, Biopharma Services, Conshohocken, Pennsylvania, USA., Kistler K; Cencora, Biopharma Services, Conshohocken, Pennsylvania, USA., Du Y; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Singh RR; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Dean BB; Cencora, Biopharma Services, Conshohocken, Pennsylvania, USA., Kong SX; Cencora, Biopharma Services, Conshohocken, Pennsylvania, USA.

Publikováno v: Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 618-625. Date of Electronic Publication: 2024 Apr 25.

Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020.

Autor: Nicholas SB; Nephrology Division, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Daratha KB; Providence Medical Research Center, Providence Inland Northwest, Spokane, Washington, USA., Alicic RZ; Providence Medical Research Center, Providence Inland Northwest, Spokane, Washington, USA.; Department of Medicine, University of Washington, Seattle, Spokane, Washington, USA., Jones CR; Providence Medical Research Center, Providence Inland Northwest, Spokane, Washington, USA., Kornowske LM; Providence Medical Research Center, Providence Inland Northwest, Spokane, Washington, USA., Neumiller JJ; Providence Medical Research Center, Providence Inland Northwest, Spokane, Washington, USA.; Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA., Fatoba ST; Bayer US, LLC, Medical Affairs, Whippany, Whippany, USA., Kong SX; Bayer US, LLC, Medical Affairs, Whippany, Whippany, USA., Singh R; Bayer US, LLC, Medical Affairs, Whippany, Whippany, USA., Norris KC; Nephrology Division, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Tuttle KR; Providence Medical Research Center, Providence Inland Northwest, Spokane, Washington, USA.; Department of Medicine, University of Washington, Seattle, Spokane, Washington, USA.; Kidney Research Institute, Institute of Translational Health Sciences, University of Washington, Seattle, Washington, USA.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Oct; Vol. 25 (10), pp. 2970-2979. Date of Electronic Publication: 2023 Jul 03.